Vadivarhe Speci.

When is the next results date for Vadivarhe Speci.?

No Upcoming Board Meetings

Has Vadivarhe Speci. declared dividend?

No Dividend History Available

Who are the peers of the Vadivarhe Speci.?

Vadivarhe Speci.'s peers include Hi-Green Carbon, Sanginita Chemi., Shri Ahimsa, Indian Emuls, Arvee Laborat., Hindcon Chemical, Indian Phosphate, Vital Chemtech, Jocil, and Paragon Fine. All peers, including Vadivarhe Speci., have a 1-year return of 0.00%.

Peers: The peers of Vadivarhe Speci. are Hi-Green Carbon, Sanginita Chemi., Shri Ahimsa, Indian Emuls, Arvee Laborat., Hindcon Chemical, Indian Phosphate, Vital Chemtech, Jocil, Paragon Fine.<BR><BR>Quality Snapshot: Excellent management risk is observed at Shri Ahimsa, Indian Emuls, and Indian Phosphate, while Good management risk is found at Hi-Green Carbon, Arvee Laborat., and Paragon Fine. Average management risk is present at Hindcon Chemical, Vital Chemtech, and Jocil, while Below Average management risk is noted at Sanginita Chemi. and Vadivarhe Speci. Growth is Excellent at Indian Emuls, Good at Shri Ahimsa, Indian Phosphate, and Paragon Fine, Average at Hi-Green Carbon and Arvee Laborat., and Below Average at Sanginita Chemi., Hindcon Chemical, Vital Chemtech, Jocil, and Vadivarhe Speci. Capital Structure is Excellent at Shri Ahimsa, Hindcon Chemical, and Jocil, Good at Hi-Green Carbon, Arvee Laborat., and Indian Phosphate, and Below Average at Sanginita Chemi., Indian Emuls, Vital Chemtech, and Vadivarhe Speci.<BR><BR>Return Snapshot: All peers, including Vadivarhe Speci., have a 1-year return of 0.00%, indicating no variation among them. There are no peers with a negative six-month return.

Is Vadivarhe Speci. overvalued or undervalued?

As of April 25, 2023, Vadivarhe Speciality is classified as risky and overvalued, with poor financial metrics including a PE ratio of -4.44 and a year-to-date return of -39.39%, significantly underperforming compared to its peers and the Sensex.

As of 25 April 2023, the valuation grade for Vadivarhe Speciality has moved from does not qualify to risky, indicating a significant shift in its financial standing. The company appears to be overvalued based on its current metrics, which include a PE ratio of -4.44, an EV to EBITDA of -12.38, and a ROE of -119.89%. These ratios suggest that the company is struggling to generate positive returns and is facing considerable financial challenges.<BR><BR>In comparison to its peers, Vadivarhe Speciality's valuation stands out negatively. For instance, Solar Industries India Ltd. is classified as very expensive with a PE ratio of 123.77, while Godrej Industries Ltd. is considered attractive with a PE ratio of 46.63. The stark contrast in valuations highlights the difficulties faced by Vadivarhe Speciality. Additionally, the company's year-to-date return of -39.39% significantly underperforms the Sensex's gain of 6.20%, further reinforcing the notion that it is currently overvalued in the market.

What is the technical trend for Vadivarhe Speci.?

As of May 29, 2025, Vadivarhe Speci. shows a bearish trend with moderate strength, supported by bearish daily moving averages and KST, despite conflicting signals from the MACD.

As of 29 May 2025, the technical trend for Vadivarhe Speci. has changed from mildly bearish to bearish. The current stance is bearish with a moderate strength. The weekly MACD is mildly bullish, but the monthly MACD indicates a bearish trend, which is a conflicting signal. The daily moving averages are bearish, reinforcing the negative outlook. Additionally, both the weekly and monthly KST are bearish, and Bollinger Bands are mildly bearish across both time frames. There are no significant signals from the RSI or Dow Theory, which show no trend. Overall, the bearish indicators dominate, suggesting caution for investors.

Who are in the management team of Vadivarhe Speci.?

As of March 2022, the management team of Vadivarhe Speci. includes Sunil H Pophale (Director), Meena S Pophale (Whole-time Director), Pramod W Gajare (Whole-time Director), and independent directors Ravindra K Paranjpe, Prasanna P Rege, and Uttara A Kher.

As of March 2022, the management team of Vadivarhe Speci. includes the following individuals:<BR><BR>1. Sunil H Pophale - Director<BR>2. Meena S Pophale - Whole-time Director<BR>3. Ravindra K Paranjpe - Independent Director<BR>4. Prasanna P Rege - Independent Director<BR>5. Uttara A Kher - Independent Director<BR>6. Pramod W Gajare - Whole-time Director<BR><BR>This team comprises both executive and independent directors, contributing to the governance and management of the company.

What does Vadivarhe Speci. do?

Vadivarhe Speciality Chemicals Ltd is a Micro Cap company in the Chemicals & Petrochemicals industry, incorporated in 2009, with recent net sales of 57 Cr and a net profit of -29 Cr as of December 2021. The company has a market cap of INR 41 Cr and significant debt, reflected in a debt-equity ratio of 3.95.

Overview:<BR>Vadivarhe Speciality Chemicals Ltd operates in the Chemicals & Petrochemicals industry and is categorized as a Micro Cap company.<BR><BR>History:<BR>The company was incorporated on February 23, 2009. Prior to its incorporation, it was promoted by Mr. Sunil Haripant Pophale under the name Fem Care Pharma Ltd, which was later taken over by Dabur India Limited in 2009. The latest quarterly results reported net sales and profit for December 2021.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 57 Cr (Quarterly Results - Dec 2021) <BR>Most recent Net Profit: -29 Cr (Quarterly Results - Dec 2021) <BR>Market-cap value: INR 41 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: N/A <BR>Industry P/E: 47 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 3.95 <BR>Return on Equity: -119.89% <BR>Price to Book: 6.30<BR><BR>Contact Details:<BR>Address: Gat No 204 Vadivarhe Igatpu, Igatpuri Maharashtra: 422403 <BR>Tel: 91-2553-282200 <BR>Email: cs@vscl.co.in / inquiry@vscl.in <BR>Website: http://www.vscl.net.in

Who are the top shareholders of the Vadivarhe Speci.?

The top shareholder of Vadivarhe Speci. is Meena Sunil Pophale, holding 47.24%, with no pledged promoter holdings. The highest public shareholder is Sanjaykumar Harikishan at 1.67%, while individual investors own 26.7% of the shares.

The top shareholders of Vadivarhe Speci. are primarily the promoters, with Meena Sunil Pophale holding the largest share at 47.24%. There are no pledged promoter holdings, and the company does not have any mutual funds or foreign institutional investors (FIIs) holding shares. The highest public shareholder is Sanjaykumar Harikishan, who owns 1.67%. Additionally, individual investors collectively hold 26.7% of the company's shares.

How big is Vadivarhe Speci.?

As of 23rd July, Vadivarhe Speciality Chemicals Ltd has a market capitalization of 38.00 Cr, with Net Sales of 23.77 Cr and a Net Profit loss of 7.52 Cr over the latest four quarters. The balance sheet for March 2024 shows Shareholder's Funds of 6.49 Cr and Total Assets of 41.61 Cr.

As of 23rd July, Vadivarhe Speciality Chemicals Ltd has a market capitalization of 38.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, the company reported Net Sales of 23.77 Cr. However, it experienced a loss of 7.52 Cr in Net Profit during the same period.<BR><BR>The latest annual period for the balance sheet is March 2024, showing Shareholder's Funds of 6.49 Cr and Total Assets amounting to 41.61 Cr.

How has been the historical performance of Vadivarhe Speci.?

Vadivarhe Speci. has experienced declining financial performance, with net sales dropping from 43.68 Cr in March 2023 to 37.91 Cr in March 2025, and significant losses in operating profit and profit after tax. The company's total liabilities increased, indicating financial pressure and ongoing challenges in cash flow generation.

Answer:<BR>The historical performance of Vadivarhe Speci. shows a fluctuating trend in key financial metrics over the years.<BR><BR>Breakdown:<BR>Vadivarhe Speci. reported net sales of 37.91 Cr in March 2025, a decline from 40.08 Cr in March 2024 and 43.68 Cr in March 2023, which were significantly higher than the 21.45 Cr recorded in March 2022. The total operating income followed a similar trend, decreasing from 40.08 Cr in March 2024 to 37.91 Cr in March 2025. The company's total expenditure increased to 44.32 Cr in March 2025, up from 36.03 Cr in March 2024, leading to an operating profit (PBDIT) of -6.14 Cr in March 2025, down from 4.54 Cr in the previous year. Profit before tax also fell to -9.27 Cr in March 2025, compared to 1.51 Cr in March 2024. Consequently, the profit after tax was -9.27 Cr in March 2025, a significant drop from 0.06 Cr in March 2024. The company's total liabilities increased to 42.73 Cr in March 2025, while total assets were reported at 42.73 Cr, indicating a balance sheet under pressure. Cash flow from operating activities was -7.00 Cr in March 2025, reflecting ongoing challenges in generating positive cash flow. Overall, the financial performance of Vadivarhe Speci. has shown a downward trajectory in recent years, particularly in profitability and cash flow metrics.

Should I buy, sell or hold Vadivarhe Speci.?

Which are the latest news on Vadivarhe Speci.?

Why is Vadivarhe Speciality Chemicals Ltd falling/rising?

As of 17-Mar, the stock price of Vadivarhe Speciality Chemicals Ltd is stable at 22.25, with a recent decline of 4.91% over the past week. Despite a strong year-to-date performance of 26.06%, the stock has faced long-term challenges, including a 20.54% decline over the past year, and declining investor participation may be affecting its current stability.

As of 17-Mar, the stock price of Vadivarhe Speciality Chemicals Ltd is currently stable at 22.25, showing no change (0.00%). Over the past week, the stock has experienced a decline of 4.91%, which is notably worse than the Sensex's decline of 2.80% during the same period. However, on a monthly basis, the stock has increased by 1.14%, contrasting with the Sensex's drop of 8.34%. Year-to-date, the stock has performed well, rising by 26.06%, while the Sensex has decreased by 9.75%. <BR><BR>Despite these positive year-to-date figures, the stock has faced challenges over the longer term, with a 20.54% decline over the past year and a significant 25.83% drop over the past three years, compared to the Sensex's gain of 4.76% and 37.90%, respectively. <BR><BR>Today's performance is described as inline with the sector, but there are signs of falling investor participation, as evidenced by a delivery volume of 3,000 shares on March 13, which has decreased by 85.29% compared to the 5-day average. This decline in trading activity may indicate a lack of investor interest, which could contribute to the stock's stability at its current price. Additionally, while the stock is trading above its 50-day and 100-day moving averages, it is below its 5-day, 20-day, and 200-day moving averages, suggesting mixed signals regarding its short-term performance. <BR><BR>Overall, while there are some positive indicators in the stock's recent performance, the significant drop in investor participation and mixed moving average signals may be contributing factors to the current price stability.

Why is Vadivarhe Speciality Chemicals Ltd falling/rising?

As of 18-Mar, the stock price of Vadivarhe Speciality Chemicals Ltd is at 22.25, unchanged from the previous session. The stock has underperformed with a significant decline over the past year and faces challenges such as low profitability and high debt, contributing to a negative outlook.

As of 18-Mar, the stock price of Vadivarhe Speciality Chemicals Ltd is currently at 22.25, showing no change from the previous trading session. The stock has experienced a decline of 4.91% over the past week, while the benchmark Sensex has only decreased by 0.37%. In the last month, the stock has risen by 1.14%, contrasting with a significant drop of 7.91% in the Sensex.<BR><BR>Year-to-date, Vadivarhe has performed well with a gain of 26.06%, while the Sensex has fallen by 9.00%. However, over the past year, the stock has seen a substantial decline of 20.54%, compared to a modest gain of 4.13% for the Sensex. The three-year performance shows a more pronounced drop of 25.83% for the stock, while the Sensex has increased by 39.05%. In the five-year period, the stock has gained 58.93%, but this is still lower than the Sensex's gain of 63.33%.<BR><BR>Today's performance indicates that the stock has underperformed its sector by 0.49%. The moving averages suggest that while the stock is above the 50-day and 100-day averages, it is below the 5-day, 20-day, and 200-day averages, indicating mixed short-term trends. Furthermore, there has been a significant decline in investor participation, with delivery volume dropping by 85.29% compared to the 5-day average.<BR><BR>The company faces several challenges that contribute to its weak long-term outlook. It has not declared results in the last six months, indicating a lack of transparency and potentially weak financial health. The high Debt to EBITDA ratio of -1.00 times suggests a low ability to service debt, and the average Return on Equity of 0.89% reflects low profitability per unit of shareholders' funds. Additionally, the stock is considered risky as it has generated a return of -20.54% over the past year, with profits plummeting by 299%.<BR><BR>In summary, the combination of declining investor participation, weak financial fundamentals, and poor performance relative to benchmarks contributes to the stock's current stagnation and overall negative sentiment.

Why is Vadivarhe Speciality Chemicals Ltd falling/rising?

As of 19-Mar, Vadivarhe Speciality Chemicals Ltd's stock price is stable at 22.25, but it has shown mixed performance with a year-to-date increase of 26.06% contrasted by a 20.54% decline over the past year. Concerns about the company's financial health are raised due to a high Debt to EBITDA ratio, low Return on Equity, and a significant profit decline, leading to cautious investor sentiment despite recent short-term gains.

As of 19-Mar, Vadivarhe Speciality Chemicals Ltd's stock price is currently stable at 22.25, showing no change (0.00%). However, the stock has exhibited a mixed performance over various periods. In the past week, it has fallen by 4.91%, while over the past month, it has risen by 1.14%. Year-to-date, the stock has shown a significant increase of 26.06%, contrasting with a decline of 20.54% over the past year.<BR><BR>Despite the recent year-to-date gains, the stock's long-term outlook appears weak. The company has not declared results in the last six months, which raises concerns about its financial health. Additionally, it has a high Debt to EBITDA ratio of -1.00 times, indicating a low ability to service its debt. The average Return on Equity is only 0.89%, reflecting low profitability per unit of shareholders' funds. Furthermore, the stock's performance has been negatively impacted by a drastic profit decline of 299% over the past year.<BR><BR>Investor participation has also decreased, with delivery volume dropping by 85.29% against the 5-day average, suggesting reduced interest in trading the stock. Although the stock outperformed its sector by 2.47% today, the overall sentiment remains cautious due to the company's weak long-term fundamentals and lack of recent financial disclosures. Therefore, while there are short-term fluctuations, the underlying factors indicate a challenging environment for Vadivarhe Speciality Chemicals Ltd.

Why is Vadivarhe Speciality Chemicals Ltd falling/rising?

As of 20-Mar, Vadivarhe Speciality Chemicals Ltd has a stable stock price of 22.25, but its long-term performance is concerning with a 20.54% decline over the past year and a significant drop in investor participation. The company's fundamentals, including a high Debt to EBITDA ratio and a 299% profit decrease, indicate serious challenges despite a recent year-to-date increase of 26.06%.

As of 20-Mar, Vadivarhe Speciality Chemicals Ltd is experiencing a stable stock price at 22.25, with no change recorded. However, the stock's performance over various periods indicates a troubling trend. Over the past year, the stock has fallen by 20.54%, and in the last three years, it has decreased by 25.83%. This decline is contrasted by a year-to-date increase of 26.06%, suggesting some recent recovery, but the overall long-term performance remains negative.<BR><BR>The stock's performance today is described as inline with the sector, yet it is important to note that there has been a significant drop in investor participation, with delivery volume falling by 85.29% compared to the five-day average. This decline in trading activity may indicate waning investor interest or confidence in the stock.<BR><BR>Moreover, the company's fundamentals raise concerns. It has not declared results in the last six months, which is a significant red flag for investors. The high Debt to EBITDA ratio of -1.00 times suggests a low ability to service debt, and the average Return on Equity of 0.89% indicates low profitability. Additionally, the stock is trading at risky levels compared to its historical valuations, and its profits have plummeted by 299% over the past year.<BR><BR>In summary, while there may be some short-term stability in the stock price, the long-term fundamentals and declining investor participation suggest that Vadivarhe Speciality Chemicals Ltd is facing significant challenges, contributing to its overall negative performance.

Why is Vadivarhe Speciality Chemicals Ltd falling/rising?

As of 23-Mar, Vadivarhe Speciality Chemicals Ltd's stock price is stable at 22.25, but it has faced significant long-term challenges, including a one-year return of -20.54% and declining investor participation. Concerns about the company's fundamentals, including high debt and poor profitability, suggest potential further declines in stock price.

As of 23-Mar, Vadivarhe Speciality Chemicals Ltd's stock price is currently stable at 22.25, showing no change (0.00%). Despite this stability in the current price, the stock has experienced a decline in the long term, with a year-to-date return of +26.06%, which contrasts sharply with a one-year return of -20.54%. This indicates that while there has been some recovery earlier in the year, the stock has faced significant challenges over the past year.<BR><BR>The stock has outperformed its sector by 3.74% today, suggesting some positive movement relative to its peers. However, the overall performance metrics indicate underlying weaknesses. The stock's delivery volume has fallen dramatically by -85.29% against the 5-day average, reflecting a decrease in investor participation, which can be a sign of declining interest or confidence in the stock.<BR><BR>Moreover, the company has not declared results in the last six months, raising concerns about its long-term fundamental strength. The high Debt to EBITDA ratio of -1.00 times and a low average Return on Equity of 0.89% further highlight the company's struggles with profitability and debt servicing. Additionally, the stock's performance over the past year, with profits falling by -299%, raises significant red flags for investors.<BR><BR>In summary, while the stock is stable at the moment, the combination of weak long-term fundamentals, declining investor participation, and poor historical performance suggests that Vadivarhe Speciality Chemicals Ltd is facing challenges that could lead to further declines in its stock price.

Why is Vadivarhe Speciality Chemicals Ltd falling/rising?

As of 24-Mar, Vadivarhe Speciality Chemicals Ltd's stock price is at 22.25, unchanged from the previous session, and has underperformed its sector by 2.39%. The stock has declined 8.06% over the past month and 20.54% over the past year, with concerns about financial stability and declining investor interest.

As of 24-Mar, Vadivarhe Speciality Chemicals Ltd's stock price is currently at 22.25, showing no change from the previous trading session. The stock has underperformed its sector today by 2.39%. Over the past week, the stock has remained flat with a change of 0.00%, while the benchmark Sensex has decreased by 2.84%. <BR><BR>In terms of longer-term performance, the stock has experienced a decline of 8.06% over the past month and a significant drop of 20.54% over the past year, contrasting with the Sensex, which has only decreased by 3.15% in the same period. The stock's year-to-date performance is relatively strong at +26.06%, especially when compared to the Sensex's -12.31%. However, the three-year performance shows a decline of 21.52%, while the Sensex has gained 35.22%.<BR><BR>The stock's current trading situation is concerning due to falling investor participation, with delivery volume dropping by 85.29% compared to the five-day average. Additionally, the stock is trading below several moving averages, indicating potential weakness in momentum. The company has not declared results in the last six months, raising concerns about its long-term fundamental strength. The high Debt to EBITDA ratio of -1.00 times and a low average Return on Equity of 0.89% further signify financial instability and low profitability.<BR><BR>Overall, the combination of weak performance metrics, declining investor interest, and financial concerns contribute to the stock's falling status.

Why is Vadivarhe Speciality Chemicals Ltd falling/rising?

As of 25-Mar, Vadivarhe Speciality Chemicals Ltd's stock price is at 21.15, down 4.94%, reflecting significant underperformance with a 12.60% drop over the past month and a 24.46% decrease over the past year. The stock is trading below key moving averages and has seen a substantial decline in investor interest, raising concerns about its financial health and long-term fundamentals.

As of 25-Mar, Vadivarhe Speciality Chemicals Ltd's stock price is falling, currently at 21.15, reflecting a decrease of 1.1 or 4.94%. This decline is part of a broader trend, as the stock has underperformed significantly over various periods, including a 12.60% drop over the past month and a 24.46% decrease over the past year. <BR><BR>The stock's performance today has also been notably poor, underperforming its sector by 6.64%. Additionally, the stock is trading below several moving averages, specifically the 5-day, 20-day, 50-day, and 200-day averages, which typically indicates a bearish trend. Furthermore, there has been a substantial decline in investor participation, with delivery volume dropping by 85.29% compared to the 5-day average, suggesting reduced interest among investors.<BR><BR>The company's long-term fundamentals appear weak, as it has not declared results in the last six months, raising concerns about its financial health. The high Debt to EBITDA ratio of -1.00 times indicates a low ability to service debt, and the average Return on Equity of 0.89% points to low profitability. Over the past year, the stock has not only generated negative returns but has also seen profits plummet by 299%. This consistent underperformance against benchmarks, including the BSE500, further contributes to the stock's declining price.